A hospital trial reports that adding chlorhexidine to an otherwise similar oral-care routine did not reduce ventilator-associated pneumonia or twenty-eight-day mortality. The finding adds to a clinical discussion about which parts of intensive-care prevention actually help. It is not a verdict on ordinary toothbrushing or instructions to stop a prescribed mouth treatment at home.
The study, published October 29 in Critical Care, concerns adults receiving mechanical ventilation in medical intensive-care units. That setting matters: these patients and their care needs differ greatly from people choosing a mouthwash at a shop.
What was tested
Six intensive-care units at one hospital in India alternated between a standardized oral-care bundle and the same bundle with 0.12% chlorhexidine. The cluster-randomized crossover study included 1,035 patients.
The adjusted pneumonia-rate comparison did not show a significant benefit from adding chlorhexidine. Mortality also did not differ significantly. ICU stay was modestly longer in the chlorhexidine group, a finding to interpret alongside the study’s other results rather than as proof of a universal harm.
Because both groups received oral care, the comparison asks about the additional ingredient. It does not test oral care against doing nothing.
Why ventilation changes the question
The CDC describes ventilator-associated pneumonia as a lung infection that can develop in someone on a ventilator. Hospital teams use infection-prevention practices and review whether breathing support remains necessary.
A person who cannot manage their own mouth care needs staff to assess and provide appropriate care. The exact procedure depends on their condition and the equipment in use.
That is why a family member should not copy a home routine at the bedside or introduce a product without speaking to the team. Good intentions do not establish that an item or technique is suitable for a ventilated patient.
Keep the clinical finding in its setting
The new comparison involved medical ICUs at a single hospital, with care organized by unit and period. That is useful real-world evidence, but it does not describe every hospital population or every reason chlorhexidine might be prescribed.
Clinical guidance has already distinguished routine oral care from routine addition of chlorhexidine for ventilated patients. The 2022 acute-care prevention update is part of that wider evidence base.
One new paper contributes to that review. It does not mean a patient or visitor should independently change an active treatment plan, nor that every antiseptic use has been evaluated by this particular trial.
Ask what the care plan includes
For a family member trying to understand ICU care, a useful question is whether an oral-care assessment and routine are part of the plan. Ask who provides it and whether there are specific concerns about the patient’s mouth or comfort.
If you notice dryness, bleeding, a loose denture or another change, tell the staff rather than trying to solve it yourself. The team can assess whether the observation affects care.
You do not need to identify the correct product or interpret an infection-rate calculation. Clear observations and questions can help the care team explain what they are doing.
Find out how you can help safely
Ask staff before touching equipment, moving the bed or offering food, drink or mouth-care items. A ventilated person may have swallowing or airway needs that are not obvious to a visitor.
Follow the hospital’s hand-hygiene and visiting instructions. If you want to bring a familiar personal item, check whether it is suitable and how it should be handled.
If several relatives visit, agree on one way to pass questions to the team so important information is not lost between conversations.
These steps do not guarantee that an infection will be prevented. They help keep the family’s role aligned with the patient’s current clinical plan rather than creating a separate, improvised routine.
What the result adds
A prevention bundle can include several sensible actions, but the value of an additional ingredient still needs testing. This trial found no clear incremental pneumonia benefit from the chlorhexidine addition in its setting.
For readers, the useful takeaway is specific: oral care remains part of patient care, while the choice of products and procedures belongs in an evidence-based clinical review. Ask about the plan, report what you notice and let the team explain any change. Do not turn a hospital study into a general instruction about what belongs in your bathroom cupboard.